Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-06 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |